Knowing that colorectal cancer tumors contain LGR5-positive CSCs (25), we analyzed the presence of LGR5+ cells in two colorectal cancer tumors by immunofluorescence (together with CD90 and EpCAM) or by flow cytometry (together with AF; Fig. 3). This evidence concerns the gene EPCAM and colorectal cancer.